Showing 681 - 700 results of 3,305 for search '"labelling"', query time: 0.07s Refine Results
  1. 681
  2. 682

    Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised, controlled trialResearch in context by Raymond J. Chan, Fiona Crawford-Williams, Chad Yixian Han, Lee Jones, Alexandre Chan, Daniel McKavanagh, Marissa Ryan, Christine Carrington, Rebecca L. Packer, Megan Crichton, Nicolas H. Hart, Emma McKinnell, Melissa Gosper, Juanita Ryan, Bethany Crowe, Ria Joseph, Carolyn Ee, Jane Lee, Steven M. McPhail, Katharine Cuff, Laisa Teleni, Jon Emery

    Published 2025-03-01
    “…Methods: In this single-centre, open-label, phase II, pilot, randomised, controlled trial, individuals diagnosed with breast cancer (Stage 0–III) were randomised 1:1 to either usual care or intervention, which includes a 1) Specialist Nurse Consultation to co-develop a survivorship care plan (SCP), 2) Pharmacist Consultation, 3) Case Conference with General Practitioner (GP), and 4) shared follow-up care arrangements. …”
    Get full text
    Article
  3. 683

    Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma by Marshall Pitz, Eng-Siew Koh, Elizabeth H Barnes, Lucille Sebastian, Mandy L Ballinger, David M Thomas, Christopher O'Callaghan, John Simes, Hui K Gan, Sonia Yip, Hao-Wen Sim, Desma Spyridopoulos, Richard De Abreu Lourenco, Cynthia Hawkins, Kristen McParland, Benjamin Kong, Subotheni Thavaneswaran, Patrick J Wheeler

    Published 2025-02-01
    “…This study aims to improve outcomes by molecular profiling of patients at relapse, then matching them with the best available drug based on their molecular profile, maximising the chances of patient benefit while simultaneously testing multiple novel drugs.Methods and analysis Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2) will be an international, phase 2, multicentre, open-label, biomarker-directed, umbrella clinical trial for recurrent isocitrate dehydrogenase mutant, histologically grade 2/3 gliomas. …”
    Get full text
    Article
  4. 684
  5. 685
  6. 686
  7. 687
  8. 688
  9. 689
  10. 690
  11. 691
  12. 692
  13. 693
  14. 694
  15. 695
  16. 696

    Pathway Of Low Anterior Resection syndrome (LARS) relief after Surgery (POLARiS): protocol for an international, open-label, multi-arm, phase 3 randomised superiority trial within a cohort, with economic evaluation, process evaluation and qualitative sub-study, to explore the natural history of LARS and compare transanal irrigation and sacral neuromodulation to optimised conservative management for people with major LARS following a high or low anterior resection for colorectal cancer by Deborah D Stocken, Charles H Knowles, Jared Torkington, David Jayne, Julie Hepburn, Laura Knight, Neil Corrigan, Julie Cornish, Katie Gordon, Ashley Douglas, Kate Wilson, Megan Dale, Julie Croft, Christina Lloydwin, Alexandra Harriet Coxon-Meggy, Judith White, Alun Meggy, Aaron Quyn, Emily Farrow, Kheng-Seong Ng, Hannah Mather, Huey Yi Chong, Betty Tan, Ralph Powell, Andrea Warwick

    Published 2025-02-01
    “…Despite this, little is known about the natural history and there is poor evidence to support current treatment options.Methods and analysis The objectives of POLARiS are to explore the natural history of LARS and to evaluate the clinical and cost-effectiveness of transanal irrigation (TAI) or sacral neuromodulation (SNM) compared with optimised conservative management (OCM) for people with major LARS.POLARiS is a prospective, international, open-label, multi-arm, phase 3 randomised superiority trial within a cohort design, with internal pilot phase, qualitative sub-study, process evaluation and economic evaluation. …”
    Get full text
    Article
  17. 697

    La labellisation, (re)qualification ou disqualification des marges ? Le cas du safran à Taliouine (Anti-Atlas, Maroc) by Mari Oiry Varacca

    Published 2020-01-01
    “…This article examines how agricultural products from marginalised mountain regions in Morocco manage to get labels. The country’s public authorities present labelling as a new way of requalifying areas that have previously been left behind. …”
    Get full text
    Article
  18. 698

    The interpretation and translation of Galatians 5:12 by D. F. Tolmie

    Published 2009-12-01
    “… As is evident from commentaries on Galatians and from various English translations, scholars do not agree on the meaning, rhetorical labelling and translation of the wish expressed by Paul in Galatians 5:12. …”
    Get full text
    Article
  19. 699

    Food-based indices for the assessment of nutritive value and environmental impact of meals and diets: A systematic review protocol. by Eva-Leanne Thomas, David Livingstone, Anne P Nugent, Jayne V Woodside, Paul Brereton

    Published 2024-01-01
    “…Though these challenges are multifaceted, shifting to healthy dietary choices from sustainable food systems is one solution. Food-based labelling is a common public-health strategy aimed at influencing consumption practices, primarily displaying front-of-pack nutrition labelling to encourage healthier choices. …”
    Get full text
    Article
  20. 700

    Da sociologia do desvio à criminologia crítica: os indígenas de Mato Grosso do Sul como outsiders by Igor Henrique da Silva Santelli, Antonio Guimarães Brito

    Published 2014-01-01
    “…In first part, it deals with the sociological approaches of Goffman, Becker and Elias, who point out the reasons and effects of stigmatization, labelling and marginalization and explain elementary fea- tures of the relationship between established people and outsiders. …”
    Get full text
    Article